Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
78.4M
-
Number of holders
-
100
-
Total 13F shares, excl. options
-
58.9M
-
Shares change
-
+9.76M
-
Total reported value, excl. options
-
$1.27B
-
Value change
-
+$161M
-
Put/Call ratio
-
1.3
-
Number of buys
-
77
-
Number of sells
-
-33
-
Price
-
$21.48
Significant Holders of Atea Pharmaceuticals, Inc. - COMMON STOCK (AVIR) as of Q2 2021
125 filings reported holding AVIR - Atea Pharmaceuticals, Inc. - COMMON STOCK as of Q2 2021.
Atea Pharmaceuticals, Inc. - COMMON STOCK (AVIR) has 100 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 58.9M shares
of 78.4M outstanding shares and own 75.11% of the company stock.
Largest 10 shareholders include FMR LLC (12.4M shares), Cormorant Asset Management, LP (6.41M shares), Bain Capital Life Sciences Investors, LLC (5.62M shares), RA CAPITAL MANAGEMENT, L.P. (5.37M shares), VANGUARD GROUP INC (4.54M shares), BlackRock Inc. (3.49M shares), PERCEPTIVE ADVISORS LLC (2.26M shares), AJU IB Investment Co., Ltd. (1.75M shares), PRICE T ROWE ASSOCIATES INC /MD/ (1.69M shares), and ABG Innovation Capital Partners III GP Ltd (1.27M shares).
This table shows the top 100 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.